-
1
-
-
25444432562
-
5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment
-
Aapro M. 5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment. Oncology 2005; 69: 97-109.
-
(2005)
Oncology
, vol.69
, pp. 97-109
-
-
Aapro, M.1
-
2
-
-
20544458329
-
Prevention and treatment of postoperative nausea and vomiting
-
Golembiewski J, Chernin E, Chopra T. Prevention and treatment of postoperative nausea and vomiting. Am J Health Syst Pharm 2005; 62: 1247-60.
-
(2005)
Am J Health Syst Pharm
, vol.62
, pp. 1247-1260
-
-
Golembiewski, J.1
Chernin, E.2
Chopra, T.3
-
3
-
-
0029898199
-
Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers
-
Benedict CR, Arbogast R, Martin L, et al. Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers. J Cardiovasc Pharmacol 1996; 28: 53-9.
-
(1996)
J Cardiovasc Pharmacol
, vol.28
, pp. 53-59
-
-
Benedict, C.R.1
Arbogast, R.2
Martin, L.3
-
4
-
-
33750337027
-
The additive interactions between ondansetron and droperidol for preventing postoperative nausea and vomiting
-
Chan MT, Choi KC, Gin T, et al. The additive interactions between ondansetron and droperidol for preventing postoperative nausea and vomiting. Anesth Analg 2006; 103: 1155-62.
-
(2006)
Anesth Analg
, vol.103
, pp. 1155-1162
-
-
Chan, M.T.1
Choi, K.C.2
Gin, T.3
-
5
-
-
19744377392
-
Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron
-
Charbit B, Albaladejo P, Funck-Brentano C, et al. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 2005; 102: 1094-100.
-
(2005)
Anesthesiology
, vol.102
, pp. 1094-1100
-
-
Charbit, B.1
Albaladejo, P.2
Funck-Brentano, C.3
-
6
-
-
34748817466
-
Droperidol-induced proarrhythmia: The beginning of an answer?
-
Charbit B, Funck-Brentano C. Droperidol-induced proarrhythmia: the beginning of an answer? Anesthesiology 2007; 107: 524-6.
-
(2007)
Anesthesiology
, vol.107
, pp. 524-526
-
-
Charbit, B.1
Funck-Brentano, C.2
-
7
-
-
48849117034
-
Droperidol and ondansetron-induced QT interval prolongation: A clinical drug interaction study
-
Charbit B, Alvarez JC, Dasque E, et al. Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study. Anesthesiology 2008; 109: 206-12.
-
(2008)
Anesthesiology
, vol.109
, pp. 206-212
-
-
Charbit, B.1
Alvarez, J.C.2
Dasque, E.3
-
8
-
-
0033772068
-
Interactions of the 5- hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels
-
Kuryshev YA, Brown AM, Wang L, et al. Interactions of the 5- hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther 2000; 295: 614-20.
-
(2000)
J Pharmacol Exp Ther
, vol.295
, pp. 614-620
-
-
Kuryshev, Y.A.1
Brown, A.M.2
Wang, L.3
-
9
-
-
34247603062
-
Molecular interaction of droperidol with human ether-a-go-go-related gene channels: Prolongation of action potential duration without inducing early afterdepolarization
-
Schwoerer AP, Blütner C, Brandt S, et al. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization. Anesthesiology 2007; 106: 967-76.
-
(2007)
Anesthesiology
, vol.106
, pp. 967-976
-
-
Schwoerer, A.P.1
Blütner, C.2
Brandt, S.3
-
10
-
-
70449499228
-
Droperidol and ondansetron in vitro electrophysiological drug interaction study
-
Weissenburger J, Funck-Brentano C, Jaillon P, et al. Droperidol and ondansetron in vitro electrophysiological drug interaction study. Fundam Clin Pharmacol 2009; 23: 719-26.
-
(2009)
Fundam Clin Pharmacol
, vol.23
, pp. 719-726
-
-
Weissenburger, J.1
Funck-Brentano, C.2
Jaillon, P.3
-
11
-
-
33748086808
-
Assessing the proarrhythmic potential of drugs: Current status of models and surrogate parameters of torsades de pointes arrhythmias
-
Thomsen MB, Matz J, Volders PGA, et al. Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmias. Pharmacol Ther 2006; 112: 150-70.
-
(2006)
Pharmacol Ther
, vol.112
, pp. 150-170
-
-
Thomsen, M.B.1
Matz, J.2
Volders, P.G.A.3
-
12
-
-
0027453628
-
Droperidol exerts dual effects on repolarization and induces early afterdepolarizations and triggered activity in rabbit Purkinje fibres
-
Adamantidis MM, Kerram P, Caron JF, et al. Droperidol exerts dual effects on repolarization and induces early afterdepolarizations and triggered activity in rabbit Purkinje fibres. J Pharmacol Exp Ther 1993; 266: 884-93.
-
(1993)
J Pharmacol Exp Ther
, vol.266
, pp. 884-893
-
-
Adamantidis, M.M.1
Kerram, P.2
Caron, J.F.3
-
13
-
-
0035901578
-
Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic
-
Hondeghem LM, Carlsson I, Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation 2001; 103: 2004-13.
-
(2001)
Circulation
, vol.103
, pp. 2004-2013
-
-
Hondeghem, L.M.1
Carlsson, I.2
Duker, G.3
-
14
-
-
0033943309
-
Comparison of L-type calcium channel blockade by nifedipine and/or cadmium in guinea pig ventricular myocytes
-
Shen JB, Jiang B, Pappano AJ. Comparison of L-type calcium channel blockade by nifedipine and/or cadmium in guinea pig ventricular myocytes. J Pharmacol Exp Ther 2000; 294: 562-70.
-
(2000)
J Pharmacol Exp Ther
, vol.294
, pp. 562-570
-
-
Shen, J.B.1
Jiang, B.2
Pappano, A.J.3
-
15
-
-
0028923941
-
Oral ondansetron decreases vomiting after tonsillectomy in children
-
Splinter WM, Baxter MR, Gould HM, et al. Oral ondansetron decreases vomiting after tonsillectomy in children. Can J Anesth 1995; 42: 277-80.
-
(1995)
Can J Anesth
, vol.42
, pp. 277-280
-
-
Splinter, W.M.1
Baxter, M.R.2
Gould, H.M.3
-
16
-
-
84873242073
-
Pharmacology 3rd edition
-
Howland RD, Mycek MJ, Harvey RA, et al. Pharmacology 3rd edition, Lippincott's Illustrated Reviews, 2008; pp. 51-9.
-
Lippincott's Illustrated Reviews
, vol.2008
, pp. 51-59
-
-
Howland, R.D.1
Mycek, M.J.2
Harvey, R.A.3
-
17
-
-
79954734112
-
IKR vs. IKS blockade and arrhythmogenicity in rabbit normoxic Purkinje fibres: Does it really make a difference?
-
Puddu PE, Legrand JC, Sallé L, et al. IKR vs. IKS blockade and arrhythmogenicity in rabbit normoxic Purkinje fibres: does it really make a difference? Fund Clin Pharmacol 2011; 25: 304-12.
-
(2011)
Fund Clin Pharmacol
, vol.25
, pp. 304-312
-
-
Puddu, P.E.1
Legrand, J.C.2
Sallé, L.3
-
18
-
-
79953740532
-
Systèmes d'acquisition de potentiels d'action: Comment mesurer les Vmax élevées?
-
Puddu PE, Rouet R, Morel M. Systèmes d'acquisition de potentiels d'action: comment mesurer les Vmax élevées? Thérapie 2010; 65: 491-8.
-
(2010)
Thérapie
, vol.65
, pp. 491-498
-
-
Puddu, P.E.1
Rouet, R.2
Morel, M.3
-
20
-
-
0030033611
-
Ondansetron blocks nifedipine-induced analgesia in rats
-
Hunti TE, Zbuzek VK. Ondansetron blocks nifedipine-induced analgesia in rats. Anesth Analg 1996; 82: 498-500.
-
(1996)
Anesth Analg
, vol.82
, pp. 498-500
-
-
Hunti, T.E.1
Zbuzek, V.K.2
-
21
-
-
29244441742
-
Ondansetron does not block tramadol-induced analgesia in mice
-
Erhan E, Onal A, Kocabas S, et al. Ondansetron does not block tramadol-induced analgesia in mice. Methods Find Exp Clin Pharmacol 2005; 27: 629-32.
-
(2005)
Methods Find Exp Clin Pharmacol
, vol.27
, pp. 629-632
-
-
Erhan, E.1
Onal, A.2
Kocabas, S.3
-
22
-
-
19944428545
-
Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil
-
Aiba T, Shimizu W, Inagaki M, et al. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil. J Am Coll Cardiol 2005; 45: 300-7.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 300-307
-
-
Aiba, T.1
Shimizu, W.2
Inagaki, M.3
-
23
-
-
33845726080
-
Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the SCN5A gene modelling human long QT syndrome 3
-
Thomas G, Gurung IS, Killeen MJ, et al. Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the SCN5A gene modelling human long QT syndrome 3. J Physiol 2007; 578: 85-97.
-
(2007)
J Physiol
, vol.578
, pp. 85-97
-
-
Thomas, G.1
Gurung, I.S.2
Killeen, M.J.3
-
24
-
-
46149098871
-
Contribution of L-type Ca2+ channels to early afterdepolarizations induced by Ikr and Iks channel suppression in guinea pig ventricular myocytes
-
Yomada M, Ohta K, Niwa A, et al. Contribution of L-type Ca2+ channels to early afterdepolarizations induced by Ikr and Iks channel suppression in guinea pig ventricular myocytes. J Membr Biol 2008; 222: 151-66.
-
(2008)
J Membr Biol
, vol.222
, pp. 151-166
-
-
Yomada, M.1
Ohta, K.2
Niwa, A.3
-
25
-
-
0033553504
-
Mechanism of block and identification of the verapamil binding domain to hERG potassium channels
-
Zhang S, Zhou Z, Gong Q, et al. Mechanism of block and identification of the verapamil binding domain to hERG potassium channels. Circ Res 1999; 84: 989-98.
-
(1999)
Circ Res
, vol.84
, pp. 989-998
-
-
Zhang, S.1
Zhou, Z.2
Gong, Q.3
|